Search the database for deliberate release of GM medicinal products
Displaying 1 - 1 of 1
|EU record number
|Company / Sponsor
|Only notified under the "contained use" procedure. Dossier submitted on 04/05/2018.
|Phase IIa clinical trial for the evaluation of a vaccin against influenza virus H3N2
|recombinant H3N2 influenza virus: 6 intern genes of the replication defective A/Puerto Rico/8/34 (PR8) strain with hemagglutinine and neuraminidase from A/Brismane/10/2007 (H3N2) strain